PI-LAB-2025-137

Thymosin Beta-4 Fragment, Independent Lab Report

Thymosin Beta-4 Fragment 5mg · Atlas Peptide Labs

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97% met the stated ≥98% claim. Content measured 98.3% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.0%

Label claimed ≥98%

Content accuracy
98.4%

4.92mg measured against 5mg claimed

Test recency
Older result

Published 17 months ago

Specimen PI-LAB-2025-137 Tested by Redpoint Laboratories 9 samples tested from this company Purity & Testing score 99/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97% Within analytical tolerance
Identity (MS) Thymosin Beta-4 Fragment Confirmed Matches label
Content 5 mg 4.92 mg Within 5% of label

Methodology & chain of custody

RP-HPLC purity with electrospray ionisation mass confirmation.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Redpoint Laboratories. See our full testing methodology.

Lot / batch
L5207-25
Purchased
Analysed
Published
Laboratory
Redpoint Laboratories
Test type
Purity & identity

Original laboratory report: PI-LAB-2025-137-report.pdf (document delivery arrives with the production storage backend)

More Tests, Atlas Peptide Labs

Sermorelin
Purity 98.2% Verified
GHRP-2
Purity 98.7% Verified
Semaglutide
Purity 98.5% Verified

More Tests, Thymosin Beta-4 Fragment

Thymosin Beta-4 Fragment Sterling Compound Co.
Purity 98.1% Verified